Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$13.62+0.77 (+5.99%)
Close on Nov 18, 2026Market cap $182.28MP/E –Yield –
Anika Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Anika Therapeutics's total debt was $25.00M at Sep 30, 2020. For fiscal 2019 it was $0, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2012 | Dec 31, 2012 | $9.60M | -14.3% |
| FY2011 | Dec 31, 2011 | $11.20M | -12.5% |
| FY2010 | Dec 31, 2010 | $12.80M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | $25.00M | – |
| Q2 FY2020 | Jun 30, 2020 | $50.00M | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
See a number that looks wrong?